Colorectal Surgery Market Report 2025

The colorectal surgery market size has grown rapidly in recent years. It will grow from $21.52 billion in 2024 to $23.83 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to the rising prevalence of colorectal disorders, growing demand for minimally invasive procedures, increased awareness of colorectal health, ongoing technological improvements in surgical instruments, and a larger geriatric population.

The colorectal surgery market size is expected to see rapid growth in the next few years. It will grow to $35.38 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to the expanding use of robotic-assisted colorectal surgeries, increased investment in healthcare infrastructure, higher incidence of colorectal cancer, growing demand for outpatient procedures, and greater awareness of early diagnosis and treatment. Key trends in the forecast period include advancements in robotic surgery technology, innovations in minimally invasive methods, integration of AI in surgical planning, progress in imaging and diagnostic tools, and improvements in postoperative care management.

The rising number of colorectal cancer cases is contributing to the expansion of the colorectal surgery market. Colorectal cancer is a malignant disease that originates in the colon or rectum, commonly beginning as noncancerous polyps that may develop into cancer over time. The increase in colorectal cancer cases is linked to lifestyle-related factors, including unhealthy diets and lack of physical activity, which elevate the risk of the disease. Colorectal surgery plays a critical role in managing this condition by removing malignant tissues and affected areas of the colon or rectum, leading to better outcomes for patients and lowering the likelihood of the disease advancing. For example, in July 2025, the Australian government agency Cancer Australia reported that approximately 15,542 new colorectal cancer cases were identified in 2024, with an estimated 5,239 deaths recorded in 2023. This growing incidence is contributing to the rising demand for colorectal surgical procedures.

Key players in the colorectal surgery industry are concentrating on the development of innovative solutions, such as incorporating AI-powered intraoperative ultrasound to increase surgical accuracy, minimize complications during surgery, enhance tumor identification, ensure precise removal margins, reduce procedure time, and improve overall patient results. This surgical technique involves combining real-time ultrasound imaging during operations with artificial intelligence algorithms to treat conditions of the colon, rectum, and anus. For instance, in June 2025, GE HealthCare, a US-based firm specializing in medical technologies, digital solutions, and pharmaceuticals, introduced the bkActiv S series. This next-generation intraoperative ultrasound system is designed to boost accuracy and surgeon confidence during colorectal and pelvic floor procedures. The bkActiv S series improves imaging quality, enabling more precise, minimally invasive interventions. Enhanced visualization during operations contributes to better clinical outcomes and expands options for nonsurgical treatment. This product release underscores GE HealthCare’s ongoing dedication to advancing medical imaging and procedural support technologies.

In April 2022, Laborie Medical Technologies, a US-based provider of medical devices and technologies, completed the acquisition of GI Supply for an undisclosed sum. Through this acquisition, Laborie Medical Technologies intends to broaden its range of products and reinforce its market position in gastrointestinal and colorectal surgical care. GI Supply is a US-based company that manufactures tools used in colorectal surgical procedures.

Major players in the colorectal surgery market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Mayo Clinic, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, Mount Sinai Health System, Olympus Corporation, Intuitive Surgical Inc., Johns Hopkins Hospital, Smith & Nephew plc, Steris plc, Karl Storz SE & Co. KG, Stanford Health Care, Cook Medical LLC, Conmed Corporation, Applied Medical Resources Corporation, Richard Wolf GmbH, Laborie Medical Technologies, CMR Surgical Ltd.

North America was the largest region in the colorectal surgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in colorectal surgery report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the colorectal surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Colorectal surgery is a branch of medicine that concentrates on diagnosing, treating, and performing surgical procedures for disorders of the colon, rectum, and anus. It covers various interventions for conditions such as colorectal cancer, diverticulitis, inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis, hemorrhoids, anal fissures, and fistulas.

The primary instruments in colorectal surgery include endoscopes, electrosurgical tools, visualization systems, handheld instruments, stapling and sealing devices, ligation clips, dilators, cutting tools including cutters and shears, and other surgical accessories. Endoscopes are devices used to visually inspect the interior of hollow organs or body cavities. Surgical procedures include right hemicolectomy, left hemicolectomy, subtotal hemicolectomy, low anterior resection, abdomino-perineal resection, and others. These procedures are indicated for colon polyps, Crohn’s disease, colorectal cancer, colitis, irritable bowel syndrome, and additional conditions. The primary users of these products are hospitals, specialty clinics, and ambulatory surgical centers.

The colorectal surgery market research report is one of a series of new reports that provides colorectal surgery market statistics, including the colorectal surgery industry global market size, regional shares, competitors with the colorectal surgery market share, detailed colorectal surgery market segments, market trends, and opportunities, and any further data you may need to thrive in the colorectal surgery industry. This colorectal surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The colorectal surgery market consists of revenues earned by entities through trans anal surgery, endoscopic procedures, and diverticulitis surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The colorectal surgery market also includes the sale of robotic surgery systems, hemostasis and suturing devices, and imaging and navigation equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.